Clinical Trials Update: Sep. 26, 2003
Asthma (Pediatric) Epilepsy Binge Eating Disorder
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication for asthma. Volunteers ages 2-8 with mild persistent asthma or a history of at least 3 or more episodes of wheezing in the previous year that lasted more than one day and affected sleep may be eligible. Research sites located throughout the United States.
A study to evaluate the safety and effectiveness of a marketed anti-seizure drug in women with catamenial epilepsy. Female volunteers ages 18-40 who have catamenial epilepsy and are currently on at least one, but no more than two anti-seizure drugs, may be eligible. Research site located in Saint Paul, Minnesota.
Binge Eating Disorder
A study to examine whether the medication sertraline (Zoloft) is effective in the treatment of binge eating disorder (BED) among overweight children and adolescents. Overweight volunteers 8-18 who have a clinical diagnosis of binge eating disorder for at least 6 months prior to study entry may be eligible. Research site located in New York, New York.
Copyright 2003 CenterWatch. All rights reserved.